Hepatitis C Virus
New findings from the United States and Poland in the area of hepatitis C virus detailed
Published in Hepatitis Weekly, July 3rd, 2006
Study 1: Recent research from the United States published in the journal Liver Transplantation has proposed an immune evasion target for hepatitis C virus (HCV).
"Liver cirrhosis and hepatocellular carcinoma secondary to chronic HCV infection requiring transplantation represents a significant public health problem. The most remarkable feature of HCV is the ability to establish chronic infection in the vast majority of cases.
"Efforts to define clinical correlates of HCV persistence have focused primarily on CD4 and CD8 T cell responses....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-07-03)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Transfected hepatitis B virus genes are expressed in early embryonic cells - Hepatitis C Genetics
Epigenetic silencing influences interferon resistance of HCV replicon-harboring cells - Hepatitis C Virus
HCV hepatoma cell entry is inhibited by oxidized low-density lipoprotein - Hepatitis C Virus
HCV NS5A protein is cleaved to produce truncated and mainly cytosolic forms - Hepatitis C Virus
HCV-reactive T cell receptor does not require CD8 for target cell recognition - Allergy & Immunology
Dynavax announces completion of enrollment in Tolamba ragweed allergy trial - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
